Skip to search formSkip to main contentSkip to account menu

S 1090

Known as: S-1090 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cephalosporins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
[Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (8)--Nephrotoxicity study in rabbits by single oral administration].
A nephrotoxicity study of Cefmatilen hydrochloride hydrate (S-1090) was conducted in rabbits at single oral doses of 250, 500 and… 
2001
2001
[Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
Cefmatilen hydrochloride hydrate (S-1090), a new non-ester type of orally active cephem antibiotic synthesized in Shionogi… 
2001
2001
[Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (7)--Three-month repeated oral dose toxicity study in juvenile dogs].
To evaluate the repeated oral dose toxicity of Cefmatilen hydrochloride hydrate (S-1090) in juvenile dogs, S-1090 was… 
2001
2001
[Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (4)--One- and three-month repeated oral dose toxicity studies in dogs].
One- or three-month repeated oral dose toxicity studies of Cefmatilen hydrochloride hydrate (S-1090) were conducted in beagle… 
2001
2001
[Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (2)--Single oral dose toxicity study in dogs].
Cefmatilen hydrochloride hydrate (S-1090) was administered at 500 and 1000 mg potency/kg once orally to beagle dogs. No deaths… 
2001
2001
[Toxicity study of cefmatilen hydrochloride hydrate (S-1090) (1)--Single oral and intravenous dose toxicity studies in rats].
A single oral dose toxicity study of Cefmatilen hydrochloride hydrate (S-1090) and a single intravenous dose toxicity study of… 
1999
1999
Determination of a new oral cephalosporin, S-1090, in human plasma and urine by direct injection high-performance liquid chromatography with ultraviolet detection and column switching.
1997
1997
In vitro antibacterial activity of a new oral cephalosporin S-1090
A new oral cephem antibiotic S-1090 was evaluated for its in vitro antibacterial activity in comparison with cefdinir… 
1996
1996
Phase I clinical studies of S-1090: Safety and pharmacokinetics
S-1090, an oral cephem antibiotic, was given to healthy male volunteers in single (10 to 400 mg) and multiple (200 mg, twice a… 
1995
1995
Transport Characteristics of S-1090, A New Oral Cephem, in Rat Intestinal Brush-Border Membrane Vesicles
AbstractPurpose. Elucidating the transport characteristics of S-1090, a new orally active cephalosporin in rat small intestinal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)